Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastrointest Endosc. Sep 16, 2013; 5(9): 433-439
Published online Sep 16, 2013. doi: 10.4253/wjge.v5.i9.433
Table 3 Tolerability and acceptability n (%)
PEG-CS + Bis (n = 78)PEG (n = 79)
GI tolerability
Nausea (no or mild)73 (93.6)72 (91.1)
Bloating (no or mild)77 (98.7)78 (98.7)
Abdominal pain/cramps (no or mild)73 (93.6)77 (97.5)
Anal irritation (no or mild)75 (96.1)77 (97.5)
Adverse events
Vomiting6 (7.7)2 (2.5)
Sweating2 (2.6)0 (0.0)
Headache3 (3.8)3 (3.8)
Shivering2 (2.6)1 (1.3)
Pre-syncope2 (2.6)0 (0.0)
Acceptability
Easy of intake (no distress)51 (65.4)48 (60.8)
Willingness to repeat the same regimen67 (85.9)71 (89.9)
Preference to current regimen123 (82.1)26 (68.4)
Urgency during the journey (no or mild)78 (100.0)79 (100.0)
Interference with sleeping (no or mild)71 (91.0)76 (96.2)